Last updated on October 2020

IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Rheumatoid Arthritis (Pediatric) | Rheumatoid Arthritis
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patient 18 years of age or older
  • Patient in whom the diagnosis of moderate to severe active rheumatoid arthritis has been confirmed by a rheumatologist
  • Patient for whom the rheumatologist decides to initiate treatment with Tofacitinib
  • Patient informed of the study

Exclusion Criteria:

  • Patient participating in a randomised clinical trial.
  • Patient presenting with a contraindication to prescription of Tofacitinib
  • Patients who are investigational site staff members or patients who are Pfizer employees directly involved in the conduct of the trial.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.